Abbott India Q4 Results
- BSE: 500488
- NSE: ABBOTINDIA
- ISIN: INE358A01014
- Sector: Biotechnology & Drugs
BSE
26,330.30
256.35 (0.98%)
256.35 (0.98%)Volume528.00
Updated: Fri 12 Jun, 2026 | 15:29:45
NSE
26,335.00270.00 (1.04%)
270.00 (1.04%)Volume9.73 K
Updated: Fri 12 Jun, 2026 | 15:29:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1,709.51 Cr.(6.54%)
- Operating Profit₹461.78 Cr.(12.46%)
- Profit After Tax₹394.93 Cr.(7.60%)
- Operating Margin27.01%(5.56%)
Note: Comparison is on YoY basis
Quarterly - Abbott India Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,247.73 | 1,279.34 | -2.47% | 1,127.29 | 4.50% |
| Depreciation/ Amortization | 19.07 | 18.77 | 1.60% | 18.19 | 6.36% |
| Operating Income | 461.78 | 444.70 | 3.84% | 311.34 | 12.46% |
| Net Income | 394.93 | 375.96 | 5.05% | 287.06 | 7.60% |
| Other Operating Expenses Total | 177.86 | 155.69 | 14.24% | 157.96 | 1.24% |
| Net Income Before Taxes | 531.23 | 508.98 | 4.37% | 389.68 | 10.05% |
| Total Revenue | 1,709.51 | 1,724.04 | -0.84% | 1,438.63 | 6.54% |
| Selling/ General/ Admin Expenses Total | 145.76 | 160.97 | -9.45% | 145.24 | 0.94% |
| Diluted Normalized EPS | 185.85 | 189.12 | -1.73% | 135.11 | 7.58% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.